Experimental assessment of temperature influence on miriplatin and cisplatin iodized-oil suspension viscosity

Jpn J Radiol. 2013 Jun;31(6):424-7. doi: 10.1007/s11604-013-0201-0. Epub 2013 Mar 24.

Abstract

Purpose: To evaluate differences in the viscosity of a platinum iodized-oil suspension on the kind of platinum agent and temperature.

Materials and methods: Viscosities of a 70 mg miriplatin and 3.5 ml iodized-oil suspension (MO suspension) and that of 100 mg cisplatin and 10 ml iodized-oil suspension (CO suspension) were evaluated at three temperatures: 25, 37, and 50 °C. Iodized-oil was used as the control. Each liquid was injected into a capillary tube and allowed to drip separately. The liquid transit time was measured, and the viscosity of each liquid was calculated at each temperature.

Results: The viscosity of each liquid decreased as the temperature increased: 43.3 ± 0.5, 39.2 ± 0.7, and 34.7 ± 0.6 mPa s for MO suspension, 41.3 ± 0.2, 36.9 ± 0.3, and 32.7 ± 0.9 mPa s for CO suspension, and 40.5 ± 0.2, 36.8 ± 0.2, and 33.8 ± 0.7 mPa s for iodized-oil at 25, 37, and 50 °C, respectively. The MO suspension group viscosity was significantly higher than that of the CO suspension group (p < 0.05) and the control (p < 0.05). Significant differences were found in viscosities among groups divided by temperature (25 °C-group vs. 37 °C-group, p < 0.05; 37 °C-group vs. 50 °C-group, p < 0.05).

Conclusion: The viscosity of the platinum iodized-oil suspension can be adjusted by changing temperature.

Publication types

  • Evaluation Study

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacokinetics*
  • Chemoembolization, Therapeutic / methods
  • Cisplatin / chemistry
  • Cisplatin / pharmacokinetics*
  • Fat Emulsions, Intravenous / pharmacokinetics
  • Humans
  • Iodized Oil / pharmacokinetics
  • Liver Neoplasms / therapy
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacokinetics*
  • Temperature*
  • Time Factors
  • Viscosity*

Substances

  • Antineoplastic Agents
  • Fat Emulsions, Intravenous
  • Organoplatinum Compounds
  • miriplatin
  • Iodized Oil
  • Cisplatin